LMR GEORGETTE PMHNP BOARD CERTIFICATION EXAM
REVIEW 2026/2027 - QUESTIONS AND ANSWERS 100%
VERIFIED COMPLETE VERIFIED ANSWERS - PASS
GUARANTEED - A+ GRADED
146 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
LMR GEORGETTE PMHNP BOARD CERTIFICATION EXAM REVIEW 2026/2027 - QUESTIONS AND
ANSWERS 100% VERIFIED COMPLETE VERIFIED ANSWERS - PASS GUARANTEED - A+ GRADED. It
contains 146 carefully selected questions that reflect the most current exam content and testing strategies. Each
question is accompanied by a correct answer and a detailed rationale that explains the underlying
pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 146 Questions
Foundations - Application - LMR Georgette Pmhnp Board Certification Review 2026/2027 AND 100
Complete PASS Guaranteed A Psychiatric-mental Health Nursing / Advanced Psychiatric Nursing Graduate /
Post-master S Certificate Pmhnp Board Certification Preparation
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
LMR Georgette Pmhnp Board 1-25 Treatment-resistant, Depression, Finding, Disorder, Clozapine
Certification Review
2026/2027 AND 100 Complete
PASS Guaranteed A
Psychiatric-mental Health
Nursing / Advanced
Psychiatric Nursing Graduate
/ Post-master S Certificate
Pmhnp Board Certification
Preparation
Finding 26-50 Disorder, Schizophrenia, Clozapine, Develops, Mechanism
Schizophrenia 51-75 Disorder, Lithium, Appropriate, Pmhnp, Therapy
Lithium 76-100 Disorder, Evidence, Current, Appropriate, Develops
Develops 101-125 Disorder, Finding, Mechanism, Self-harm, Depression
Treatment-resistant 126-146 Disorder, Finding, Specifically, Clozapine, Develops
TOTAL 146 All questions include answers and detailed rationales
,Section A - LMR Georgette Pmhnp Board Certification
Review 2026/2027 AND 100 Complete PASS Guaranteed A
Psychiatric-mental Health Nursing / Advanced Psychiatric
Nursing Graduate / Post-master S Certificate Pmhnp Board
Certification Preparation
Q1.
A patient with treatment-resistant bipolar I depression is being considered for esketamine
augmentation. Which baseline finding would most strongly contraindicate this therapy?
A. History of two prior manic episodes with B. Current use of a monoamine oxidase
psychotic features inhibitor (MAOI)
C. Documented aneurysmal subarachnoid D. Serum creatinine of 1.4 mg/dL with eGFR
hemorrhage history 52
Correct: C - Documented aneurysmal subarachnoid hemorrhage history
Rationale:Esketamine carries a boxed warning for aneurysmal vascular disease due to risk of
hypertensive crisis and hemorrhage. MAOI use is a relative contraindication requiring
washout but not absolute. Prior mania is expected in bipolar depression and not a
contraindication. Mild renal impairment does not absolutely contraindicate.
Q2.
A patient on clozapine for 6 months presents with fever, tachycardia, and a clozapine level
of 1200 ng/mL. Which complication is most immediately life-threatening?
A. Myocarditis B. Severe neutropenia
C. Seizure D. Constipation with ileus
Correct: A - Myocarditis
Rationale:Myocarditis typically occurs within the first 2 months but can present later; fever
and tachycardia with elevated clozapine levels strongly suggest myocarditis, which can
rapidly progress to heart failure and is life-threatening. Neutropenia is also serious but usually
detected via monitoring. Seizures are dose-related but less acutely fatal. Ileus is a concern
but not as immediately life-threatening.
Q3.
Which neurobiological mechanism best explains the rapid antidepressant effect of
ketamine in treatment-resistant depression?
A. Direct agonism at 5-HT2A receptors B. Inhibition of monoamine oxidase A
Page 3
, Section A - LMR Georgette Pmhnp Board Certification Review 2026/2027 AND 100 Complete PASS Guaranteed A Psychiatric-mental Health
Nursing / Advanced Psychiatric Nursing Graduate / Post-master S Certificate Pmhnp Board Certification Preparation
C. Antagonism of NMDA receptors on D. Blockade of dopamine D2 receptors in
GABAergic interneurons leading to the mesolimbic pathway
glutamate surge and AMPA-mediated
synaptogenesis
Correct: C - Antagonism of NMDA receptors on GABAergic interneurons leading to
glutamate surge and AMPA-mediated synaptogenesis
Rationale:Ketamine's rapid effect is attributed to NMDA receptor antagonism on GABAergic
interneurons, disinhibiting glutamate release, which then activates AMPA receptors and
triggers mTOR-mediated synaptogenesis. This differs from traditional monoaminergic
mechanisms. The other options describe mechanisms of other drug classes.
Q4.
A patient with borderline personality disorder engages in self-harm and reports intense
fear of abandonment. Which therapeutic approach has the strongest evidence for
reducing self-harm and improving emotional regulation?
A. Cognitive behavioral therapy (CBT) B. Dialectical behavior therapy (DBT)
C. Psychodynamic psychotherapy D. Mentalization-based therapy (MBT)
Correct: B - Dialectical behavior therapy (DBT)
Rationale:DBT has the most robust evidence for reducing self-harm and improving emotion
regulation in borderline personality disorder. CBT and psychodynamic therapy have some
support but less consistent evidence for self-harm reduction. MBT is effective for improving
mentalizing and reducing suicidality but DBT remains first-line per current guidelines.
Q5.
Which finding on a routine metabolic panel would most urgently prompt intervention in a
patient taking olanzapine?
A. Fasting glucose 102 mg/dL B. Triglycerides 180 mg/dL
C. ALT 45 U/L D. HbA1c 7.2% with new polyuria
Correct: D - HbA1c 7.2% with new polyuria
Rationale:An HbA1c of 7.2% with new polyuria suggests new-onset diabetes mellitus, a
serious metabolic adverse effect of olanzapine requiring immediate management. Mild
hyperglycemia, borderline triglycerides, and mildly elevated ALT warrant monitoring but are
not as urgent as symptomatic hyperglycemia.
Page 4
REVIEW 2026/2027 - QUESTIONS AND ANSWERS 100%
VERIFIED COMPLETE VERIFIED ANSWERS - PASS
GUARANTEED - A+ GRADED
146 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
LMR GEORGETTE PMHNP BOARD CERTIFICATION EXAM REVIEW 2026/2027 - QUESTIONS AND
ANSWERS 100% VERIFIED COMPLETE VERIFIED ANSWERS - PASS GUARANTEED - A+ GRADED. It
contains 146 carefully selected questions that reflect the most current exam content and testing strategies. Each
question is accompanied by a correct answer and a detailed rationale that explains the underlying
pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 146 Questions
Foundations - Application - LMR Georgette Pmhnp Board Certification Review 2026/2027 AND 100
Complete PASS Guaranteed A Psychiatric-mental Health Nursing / Advanced Psychiatric Nursing Graduate /
Post-master S Certificate Pmhnp Board Certification Preparation
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
LMR Georgette Pmhnp Board 1-25 Treatment-resistant, Depression, Finding, Disorder, Clozapine
Certification Review
2026/2027 AND 100 Complete
PASS Guaranteed A
Psychiatric-mental Health
Nursing / Advanced
Psychiatric Nursing Graduate
/ Post-master S Certificate
Pmhnp Board Certification
Preparation
Finding 26-50 Disorder, Schizophrenia, Clozapine, Develops, Mechanism
Schizophrenia 51-75 Disorder, Lithium, Appropriate, Pmhnp, Therapy
Lithium 76-100 Disorder, Evidence, Current, Appropriate, Develops
Develops 101-125 Disorder, Finding, Mechanism, Self-harm, Depression
Treatment-resistant 126-146 Disorder, Finding, Specifically, Clozapine, Develops
TOTAL 146 All questions include answers and detailed rationales
,Section A - LMR Georgette Pmhnp Board Certification
Review 2026/2027 AND 100 Complete PASS Guaranteed A
Psychiatric-mental Health Nursing / Advanced Psychiatric
Nursing Graduate / Post-master S Certificate Pmhnp Board
Certification Preparation
Q1.
A patient with treatment-resistant bipolar I depression is being considered for esketamine
augmentation. Which baseline finding would most strongly contraindicate this therapy?
A. History of two prior manic episodes with B. Current use of a monoamine oxidase
psychotic features inhibitor (MAOI)
C. Documented aneurysmal subarachnoid D. Serum creatinine of 1.4 mg/dL with eGFR
hemorrhage history 52
Correct: C - Documented aneurysmal subarachnoid hemorrhage history
Rationale:Esketamine carries a boxed warning for aneurysmal vascular disease due to risk of
hypertensive crisis and hemorrhage. MAOI use is a relative contraindication requiring
washout but not absolute. Prior mania is expected in bipolar depression and not a
contraindication. Mild renal impairment does not absolutely contraindicate.
Q2.
A patient on clozapine for 6 months presents with fever, tachycardia, and a clozapine level
of 1200 ng/mL. Which complication is most immediately life-threatening?
A. Myocarditis B. Severe neutropenia
C. Seizure D. Constipation with ileus
Correct: A - Myocarditis
Rationale:Myocarditis typically occurs within the first 2 months but can present later; fever
and tachycardia with elevated clozapine levels strongly suggest myocarditis, which can
rapidly progress to heart failure and is life-threatening. Neutropenia is also serious but usually
detected via monitoring. Seizures are dose-related but less acutely fatal. Ileus is a concern
but not as immediately life-threatening.
Q3.
Which neurobiological mechanism best explains the rapid antidepressant effect of
ketamine in treatment-resistant depression?
A. Direct agonism at 5-HT2A receptors B. Inhibition of monoamine oxidase A
Page 3
, Section A - LMR Georgette Pmhnp Board Certification Review 2026/2027 AND 100 Complete PASS Guaranteed A Psychiatric-mental Health
Nursing / Advanced Psychiatric Nursing Graduate / Post-master S Certificate Pmhnp Board Certification Preparation
C. Antagonism of NMDA receptors on D. Blockade of dopamine D2 receptors in
GABAergic interneurons leading to the mesolimbic pathway
glutamate surge and AMPA-mediated
synaptogenesis
Correct: C - Antagonism of NMDA receptors on GABAergic interneurons leading to
glutamate surge and AMPA-mediated synaptogenesis
Rationale:Ketamine's rapid effect is attributed to NMDA receptor antagonism on GABAergic
interneurons, disinhibiting glutamate release, which then activates AMPA receptors and
triggers mTOR-mediated synaptogenesis. This differs from traditional monoaminergic
mechanisms. The other options describe mechanisms of other drug classes.
Q4.
A patient with borderline personality disorder engages in self-harm and reports intense
fear of abandonment. Which therapeutic approach has the strongest evidence for
reducing self-harm and improving emotional regulation?
A. Cognitive behavioral therapy (CBT) B. Dialectical behavior therapy (DBT)
C. Psychodynamic psychotherapy D. Mentalization-based therapy (MBT)
Correct: B - Dialectical behavior therapy (DBT)
Rationale:DBT has the most robust evidence for reducing self-harm and improving emotion
regulation in borderline personality disorder. CBT and psychodynamic therapy have some
support but less consistent evidence for self-harm reduction. MBT is effective for improving
mentalizing and reducing suicidality but DBT remains first-line per current guidelines.
Q5.
Which finding on a routine metabolic panel would most urgently prompt intervention in a
patient taking olanzapine?
A. Fasting glucose 102 mg/dL B. Triglycerides 180 mg/dL
C. ALT 45 U/L D. HbA1c 7.2% with new polyuria
Correct: D - HbA1c 7.2% with new polyuria
Rationale:An HbA1c of 7.2% with new polyuria suggests new-onset diabetes mellitus, a
serious metabolic adverse effect of olanzapine requiring immediate management. Mild
hyperglycemia, borderline triglycerides, and mildly elevated ALT warrant monitoring but are
not as urgent as symptomatic hyperglycemia.
Page 4
